# YUM Brands Inc: financial statements, quarterly

YUM · NYSE · CIK 1041061 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/yum.md) · [Financials](/companies/yum/financials.md) · [Filings](/companies/yum/filings.md) · [Insiders](/companies/yum/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/yum/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,708](/filings/0001041061-24-000039.md) | [2,036 d](/filings/0001041061-26-000084.md) | [1,598](/filings/0001041061-25-000025.md) | [1,763](/filings/0001041061-25-000057.md) | [1,826](/filings/0001041061-25-000109.md) | [2,362 d](/filings/0001041061-26-000084.md) | [1,787](/filings/0001041061-26-000119.md) | [1,933](/filings/0001041061-26-000160.md) | [1,979](/filings/0001041061-25-000109.md) | [2,515 d](/filings/0001041061-26-000084.md) | [2,059](/filings/0001041061-26-000119.md) | [2,169](/filings/0001041061-26-000160.md) |
| Cost of revenue | $m | [421](/filings/0001041061-24-000039.md) | [535 d](/filings/0001041061-26-000084.md) | [400](/filings/0001041061-25-000025.md) | [470](/filings/0001041061-25-000057.md) | [523](/filings/0001041061-25-000109.md) | [727 d](/filings/0001041061-26-000084.md) | [520](/filings/0001041061-26-000119.md) | [560](/filings/0001041061-26-000160.md) | [587](/filings/0001041061-25-000109.md) | [815 d](/filings/0001041061-26-000084.md) | [677](/filings/0001041061-26-000119.md) | [700](/filings/0001041061-26-000160.md) |
| Operating income | $m | [613](/filings/0001041061-24-000039.md) | [609 d](/filings/0001041061-26-000084.md) | [520](/filings/0001041061-25-000025.md) | [607](/filings/0001041061-25-000057.md) | [619](/filings/0001041061-25-000109.md) | [657 d](/filings/0001041061-26-000084.md) | [548](/filings/0001041061-26-000119.md) | [622](/filings/0001041061-26-000160.md) | [666](/filings/0001041061-25-000109.md) | [738 d](/filings/0001041061-26-000084.md) | [644](/filings/0001041061-26-000119.md) | [655](/filings/0001041061-26-000160.md) |
| Income tax | $m | [89.0](/filings/0001041061-24-000039.md) | [30.0](/filings/0001041061-24-000011.md) | [69.0](/filings/0001041061-25-000025.md) | [120](/filings/0001041061-25-000057.md) | [120](/filings/0001041061-25-000109.md) | [105 d](/filings/0001041061-26-000084.md) | [176](/filings/0001041061-26-000119.md) | [125](/filings/0001041061-26-000160.md) | [144](/filings/0001041061-25-000109.md) | [72.0 d](/filings/0001041061-26-000084.md) | [84.0](/filings/0001041061-26-000119.md) | [(320)](/filings/0001041061-26-000160.md) |
| Net income | $m | [416](/filings/0001041061-24-000039.md) | [463 d](/filings/0001041061-26-000084.md) | [314](/filings/0001041061-25-000025.md) | [367](/filings/0001041061-25-000057.md) | [382](/filings/0001041061-25-000109.md) | [423 d](/filings/0001041061-26-000084.md) | [253](/filings/0001041061-26-000119.md) | [374](/filings/0001041061-26-000160.md) | [397](/filings/0001041061-25-000109.md) | [535 d](/filings/0001041061-26-000084.md) | [432](/filings/0001041061-26-000119.md) | [853](/filings/0001041061-26-000160.md) |
| Diluted EPS | $ per share | [1.46](/filings/0001041061-24-000039.md) | not reported | [1.10](/filings/0001041061-25-000025.md) | [1.28](/filings/0001041061-25-000057.md) | [1.35](/filings/0001041061-25-000109.md) | not reported | [0.90](/filings/0001041061-26-000119.md) | [1.33](/filings/0001041061-26-000160.md) | [1.41](/filings/0001041061-25-000109.md) | not reported | [1.55](/filings/0001041061-26-000119.md) | [3.08](/filings/0001041061-26-000160.md) |
| Basic EPS | $ per share | [1.48](/filings/0001041061-24-000039.md) | not reported | [1.11](/filings/0001041061-25-000025.md) | [1.30](/filings/0001041061-25-000057.md) | [1.36](/filings/0001041061-25-000109.md) | not reported | [0.91](/filings/0001041061-26-000119.md) | [1.34](/filings/0001041061-26-000160.md) | [1.42](/filings/0001041061-25-000109.md) | not reported | [1.56](/filings/0001041061-26-000119.md) | [3.10](/filings/0001041061-26-000160.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0001041061-23-000050.md) | [0.5](/filings/0001041061-26-000084.md) | [0.7](/filings/0001041061-24-000020.md) | [0.4](/filings/0001041061-24-000033.md) | [0.5](/filings/0001041061-24-000039.md) | [0.6](/filings/0001041061-26-000084.md) | [0.6](/filings/0001041061-25-000025.md) | [0.7](/filings/0001041061-25-000057.md) | [1.0](/filings/0001041061-25-000109.md) | [0.7](/filings/0001041061-26-000160.md) | [0.7](/filings/0001041061-26-000119.md) | [0.7](/filings/0001041061-26-000160.md) |
| Current assets | $bn | [1.7](/filings/0001041061-23-000050.md) | [1.6](/filings/0001041061-25-000013.md) | [1.8](/filings/0001041061-24-000020.md) | [1.6](/filings/0001041061-24-000033.md) | [1.6](/filings/0001041061-24-000039.md) | [1.9](/filings/0001041061-26-000084.md) | [1.7](/filings/0001041061-25-000025.md) | [1.8](/filings/0001041061-25-000057.md) | [2.2](/filings/0001041061-25-000109.md) | [2.0](/filings/0001041061-26-000160.md) | [2.0](/filings/0001041061-26-000119.md) | [2.5](/filings/0001041061-26-000160.md) |
| Total assets | $bn | [6.1](/filings/0001041061-23-000050.md) | [6.2](/filings/0001041061-25-000013.md) | [6.2](/filings/0001041061-24-000020.md) | [6.4](/filings/0001041061-24-000033.md) | [6.5](/filings/0001041061-24-000039.md) | [6.7](/filings/0001041061-26-000084.md) | [6.7](/filings/0001041061-25-000025.md) | [6.9](/filings/0001041061-25-000057.md) | [7.2](/filings/0001041061-25-000109.md) | [8.2](/filings/0001041061-26-000160.md) | [8.2](/filings/0001041061-26-000119.md) | [8.7](/filings/0001041061-26-000160.md) |
| Current liabilities | $bn | [1.5](/filings/0001041061-23-000050.md) | [1.3](/filings/0001041061-25-000013.md) | [1.2](/filings/0001041061-24-000020.md) | [1.1](/filings/0001041061-24-000033.md) | [1.2](/filings/0001041061-24-000039.md) | [1.3](/filings/0001041061-26-000084.md) | [1.2](/filings/0001041061-25-000025.md) | [2.2](/filings/0001041061-25-000057.md) | [1.3](/filings/0001041061-25-000109.md) | [1.5](/filings/0001041061-26-000160.md) | [3.1](/filings/0001041061-26-000119.md) | [4.3](/filings/0001041061-26-000160.md) |
| Total liabilities | $bn | [14.3](/filings/0001041061-23-000050.md) | [14.1](/filings/0001041061-25-000013.md) | [14.0](/filings/0001041061-24-000020.md) | [14.0](/filings/0001041061-24-000033.md) | [14.1](/filings/0001041061-24-000039.md) | [14.4](/filings/0001041061-26-000084.md) | [14.5](/filings/0001041061-25-000025.md) | [14.6](/filings/0001041061-25-000057.md) | [14.7](/filings/0001041061-25-000109.md) | [15.5](/filings/0001041061-26-000160.md) | [15.5](/filings/0001041061-26-000119.md) | [15.8](/filings/0001041061-26-000160.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.4](/filings/0001041061-23-000050.md) | [0.1](/filings/0001041061-24-000039.md) | [0.1](/filings/0001041061-24-000020.md) | [0.0](/filings/0001041061-24-000033.md) | [0.0](/filings/0001041061-24-000039.md) | [0.0](/filings/0001041061-25-000109.md) | [0.0](/filings/0001041061-25-000025.md) | [1.0](/filings/0001041061-25-000057.md) | [0.0](/filings/0001041061-25-000109.md) | [0.0](/filings/0001041061-26-000160.md) | [1.8](/filings/0001041061-26-000119.md) | [2.8](/filings/0001041061-26-000160.md) |
| Short-term borrowings | $bn | [0.4](/filings/0001041061-23-000050.md) | [0.1](/filings/0001041061-25-000013.md) | [0.1](/filings/0001041061-24-000020.md) | [0.0](/filings/0001041061-24-000033.md) | [0.0](/filings/0001041061-24-000039.md) | [0.0](/filings/0001041061-26-000084.md) | [0.0](/filings/0001041061-25-000025.md) | [1.0](/filings/0001041061-25-000057.md) | [0.0](/filings/0001041061-25-000109.md) | [0.0](/filings/0001041061-26-000160.md) | [1.7](/filings/0001041061-26-000119.md) | [2.8](/filings/0001041061-26-000160.md) |
| Shareholders' equity | $bn | [(8.2)](/filings/0001041061-24-000039.md) | [(7.9)](/filings/0001041061-25-000109.md) | [(7.8)](/filings/0001041061-25-000057.md) | [(7.6)](/filings/0001041061-25-000109.md) | [(7.7)](/filings/0001041061-25-000109.md) | [(7.6)](/filings/0001041061-26-000160.md) | [(7.8)](/filings/0001041061-26-000160.md) | [(7.7)](/filings/0001041061-26-000160.md) | [(7.5)](/filings/0001041061-25-000109.md) | [(7.3)](/filings/0001041061-26-000160.md) | [(7.3)](/filings/0001041061-26-000160.md) | [(7.1)](/filings/0001041061-26-000160.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [477 d](/filings/0001041061-24-000039.md) | [448 d](/filings/0001041061-26-000084.md) | [363](/filings/0001041061-25-000025.md) | [342 d](/filings/0001041061-25-000057.md) | [471 d](/filings/0001041061-25-000109.md) | [513 d](/filings/0001041061-26-000084.md) | [404](/filings/0001041061-26-000119.md) | [446 d](/filings/0001041061-26-000160.md) | [543 d](/filings/0001041061-25-000109.md) | [617 d](/filings/0001041061-26-000084.md) | [416](/filings/0001041061-26-000119.md) | [507 d](/filings/0001041061-26-000160.md) |
| Capital expenditure | $m | [57.0 d](/filings/0001041061-24-000039.md) | [106 d](/filings/0001041061-26-000084.md) | [49.0](/filings/0001041061-25-000025.md) | [50.0 d](/filings/0001041061-25-000057.md) | [52.0 d](/filings/0001041061-25-000109.md) | [106 d](/filings/0001041061-26-000084.md) | [71.0](/filings/0001041061-26-000119.md) | [71.0 d](/filings/0001041061-26-000160.md) | [94.0 d](/filings/0001041061-25-000109.md) | [135 d](/filings/0001041061-26-000084.md) | [75.0](/filings/0001041061-26-000119.md) | [100 d](/filings/0001041061-26-000160.md) |
| Dividends paid | $m | [169 d](/filings/0001041061-24-000039.md) | [170 d](/filings/0001041061-26-000084.md) | [189](/filings/0001041061-25-000025.md) | [188 d](/filings/0001041061-25-000057.md) | [188 d](/filings/0001041061-25-000109.md) | [187 d](/filings/0001041061-26-000084.md) | [198](/filings/0001041061-26-000119.md) | [197 d](/filings/0001041061-26-000160.md) | [197 d](/filings/0001041061-25-000109.md) | [197 d](/filings/0001041061-26-000084.md) | [207](/filings/0001041061-26-000119.md) | [206 d](/filings/0001041061-26-000160.md) |
| Share repurchases | $m | [0.0 d](/filings/0001041061-24-000039.md) | [0.0 d](/filings/0001041061-26-000084.md) | [0.0](/filings/0001041061-25-000025.md) | [50.0 d](/filings/0001041061-25-000057.md) | [277 d](/filings/0001041061-25-000109.md) | [114 d](/filings/0001041061-26-000084.md) | [229](/filings/0001041061-26-000119.md) | [109 d](/filings/0001041061-26-000160.md) | [36.0 d](/filings/0001041061-25-000109.md) | [178 d](/filings/0001041061-26-000084.md) | [185](/filings/0001041061-26-000119.md) | [489 d](/filings/0001041061-26-000160.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [289](/filings/0001041061-23-000050.md) | [285](/filings/0001041061-24-000020.md) | [286](/filings/0001041061-24-000033.md) | [286](/filings/0001041061-24-000039.md) | [286](/filings/0001041061-25-000025.md) | [286](/filings/0001041061-25-000057.md) | [285](/filings/0001041061-25-000109.md) | [282](/filings/0001041061-26-000119.md) | [281](/filings/0001041061-26-000160.md) | [281](/filings/0001041061-25-000109.md) | [279](/filings/0001041061-26-000119.md) | [277](/filings/0001041061-26-000160.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 272,901,085 at 2026-07-30, from the cover of the [10-Q filed 2026-08-05](/filings/0001041061-26-000160.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.